Please use this identifier to cite or link to this item:
Title: COVID-19 drug practices risk antimicrobial resistance evolution
Authors: Afshinnekoo, Ebrahim
Bhattacharya, Chandrima
Burguete-García, A.
Castro-Nallar, Eduardo
Deng, Youping
Desnues, Christelle
Dias-Neto, Emmanuel
Elhaik, Eran
Iraola, Gregorio
Jang, Soojin
?abaj, P.P.
Mason, Christopher E.
Nagarajan, Niranjan 
Poulsen, Michael
Prithiviraj, Bharath
Siam, Rania
Shi, Tieliu
Suzuki, Haruo
Werner, Johannes
Mercedes Zambrano, Maria
Bhattacharyya, Malay
MetaSUB Consortium.
Issue Date: 1-Apr-2021
Publisher: Elsevier Ltd
Citation: Afshinnekoo, Ebrahim, Bhattacharya, Chandrima, Burguete-García, A., Castro-Nallar, Eduardo, Deng, Youping, Desnues, Christelle, Dias-Neto, Emmanuel, Elhaik, Eran, Iraola, Gregorio, Jang, Soojin, ?abaj, P.P., Mason, Christopher E., Nagarajan, Niranjan, Poulsen, Michael, Prithiviraj, Bharath, Siam, Rania, Shi, Tieliu, Suzuki, Haruo, Werner, Johannes, Mercedes Zambrano, Maria, Bhattacharyya, Malay, MetaSUB Consortium. (2021-04-01). COVID-19 drug practices risk antimicrobial resistance evolution. The Lancet Microbe 2 (4). ScholarBank@NUS Repository.
Rights: Attribution-NonCommercial-NoDerivatives 4.0 International
Source Title: The Lancet Microbe
ISSN: 2666-5247
DOI: 10.1016/s2666-5247(21)00039-2
Rights: Attribution-NonCommercial-NoDerivatives 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1016_s2666-5247(21)00039-2.pdf193.18 kBAdobe PDF




checked on Nov 21, 2022

Page view(s)

checked on Nov 17, 2022

Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons